Lanchi Ventures leads $42m Series A round for Chinese biotech startup Allink 2024-11-28T18:55:49-05:00November 28th, 2024| share this article![#item_full_content] Read More share this article! Related Posts Opinion | Trump tariffs could be a blessing in disguise for China’s reformers November 28th, 2024 Korean Air-Asiana merger to move ahead after EU review ends November 28th, 2024 Japan researchers make breakthrough in black truffle farming November 28th, 2024 MUFG to launch takeover bid for robo-adviser WealthNavi November 28th, 2024
